Answers are grounded in this paper and cite their sources.
Weight loss is a frequent occurrence among patients with head and neck cancer (HNC) and can be observed before, during, and after cancer treatment, especially radiation therapy (RT) with or without concurrent chemotherapy (CRT). Patients with HNC are at a high risk of malnutrition at the time of diagnosis, and nutritional support or intervention is often needed during and after RT or concurrent CRT. Given the severe consequences of malnutrition and cachexia on treatment outcomes, mortality, morbidity, and quality of life, it is essential to identify patients who are at higher risk of developing this condition. The nutritional status of patients is a crucial factor in terms of adherence to treatment and recovery. Malnutrition may have a significant impact on treatment outcomes and consequently tumor progression. However, in clinical practice, identifying and standardising nutritional interventions can be challenging. In this commentary, we aim to identify the components of screening and assessment that are commonly used in both literature and clinical practice and suggest the appropriate timing for nutritional interventions in patients with HNC undergoing RT or CRT.At the time of diagnosis, 35 to 60% of Head and Neck Cancer (HNC) patients are malnourished due to cancer-related impairment such as pain, obstruction or loss of appetite (1,2). Compared to patients with other primary neoplasms, HNC patients are at a higher risk of malnutrition due to the location of the tumor and the impact of the treatment-related side effects on quality of life (3,4). Indeed malnutrition can cause a range of clinical symptoms, including metabolic and electrolytic imbalances, immune system depression, and increased morbidity and mortality (5). Weight loss can lead to discontinue cancer treatments and to a negative impact on oncological outcomes, with around 55% of patients losing an additional 10% or more of their body weight during RT or CRT (5–7). This note aims to provide an overview on the role of nutritional counselling in HNC patients undergoing CRT, either in an exclusive or adjuvant setting.Malnutrition screening is an essential component of multimodal care in HNC patients. It involves the systematic identification of patients who are at risk of malnutrition and the provision of appropriate interventions to prevent or treat malnutrition (8). In this regard, the European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines for screening suggests that the purpose of nutritional screening is to predict the outcome and the impact of nutritional intervention (9).There are no standardized guidelines regarding nutritional screening. Screening should occur at the time of diagnosis, before treatment begins, and at regular intervals throughout treatment and follow-up. This allows for early identification of malnutrition and timely intervention to prevent or treat it. Despite its acknowledged role, there are no standardized guidelines regarding nutritional screening.The risk of malnutrition is frequent in HNC patients and for this reason it is mandatory to primarily identify patients at higher risk. Currently, standardized parameters are adopted and although there is not a single assessment tool, we believe that the use of a standardized assessment is essential to identify patients at risk at baseline. The commonly used nutrition assessment tools are:1. Mini Nutrition Assessment(MNA) includes anthropometric, general, dietary and autonomy of food self-assessments (self-perception of health and nutrition) (10–12). 2. Nutritional Risk Screening 2002(NRS2002) detects the presence or the risk of undernutrition (9,13).3. Patient-generated Subjective Globe Assessment(PG-SGA) is focused on the preeminent interdisciplinary patient assessment and allows for triaging of nutrition interventions(14).4. Malnutrition Universal Screening Tool(MUST) is a five-step screening tool to identify malnourished adults(15,16).The appropriate nutritional assessment should be performed for all patients before CRT. For defining the severity of malnutrition, we recommend the use of the new GLIM (Global Leadership Initiative on Malnutrition) score, already adopted by ESPEN, ASPEN, FELANPE and PENSA. In particular, the GLIM includes three phenotypical criteria (weight loss, low BMI, and reduced muscle mass) and two etiological criteria (reduced food intake or absorption, and increased disease burden or inflammation)(17).The aim of the nutritional intervention is to improve the subjective quality of life, enhance anti-tumour treatment effects, reduce the adverse effects of oncological care, prevent the interruption of therapy and treat RT/CRT-related undernutrition. In this regard, Table 1 summarizes the main studies analyzing the impact of nutritional counselling and nutritional intervention strategies in HNC patients(18,19,28–32,20–27). The onset of oral mucositis in HNC patients during RT or CRT may result in weight loss and intensive dietary counselling and oral nutrition support is recommended. This is also advised to prevent interruptions to CRT (33). There are different types of nutritional support that can be adopted to reach the needs of the patient. Main options of nutritional support are oral, enteral and parenteral. Nutritional interventions include relaxation of previous therapeutic diets, to minimise further nutritional compromise and to positively influence quality of life outcomes (34). However, this may not necessarily be appropriate, due to the side effects and intensity of treatment regimens. Patients may require more intensive nutritional support methods from the beginning of treatment over and above traditional food fortification methods with the early use of oral nutrition support. The choice of feeding route in HNC patients will depend upon local arrangements, however clinical considerations should include: site of primary tumour, treatment plan and intent, predicted duration of enteral feeding and patient choice (35,36). Tube feeding is recommended if swallowing is impaired or if mucositis is anticipated, which may interfere with oral and/or pharyngeal functionality. If enteral feeding is expected to be required for longer than four weeks, then gastrostomy insertion is recommended but not in a prevention way, except for limited cases (37). The optimal method of tube feeding still remains unclear and any approach should be discussed with the patient in order to ensure an individualised nutritional care. Moreover, the optimal screening and assessment for suitability and method of gastrostomy insertion by endoscopic, radiological or surgical approach is essential. Assessment of co-morbidities and contraindications should be taken into account to prevent complications prior to oncological treatment (35,36).The type and volume of enteral nutrition will depend upon patients’ symptoms and current intake and is likely to change throughout and after treatment. There are no data to suggest a role for cancer-specific enteral formulae. Monitoring nutritional intervention is essential, as compliance with recommendations can be a problem and should be organized weekly during CRT. Supplementation with immunonutrient-enriched formulas such as arginine, nucleotides (RNA) and omega-3 fatty acids up to the end of (C)RT or until withdrawal in HNC patients during RT and CRT may improve or maintain nutrition status(37–39). Moreover it can delay the onset of oral mucositis and reduce the incidence of severe oral mucositis (38–40). Much evidence is showing a possible beneficial effect of immunonutrition on the control of the onset of local recurrences of the disease after esophagectomy, an improvement in immunosurveillance mechanisms, and a reduction in inflammatory status. Finally, by modulating gene expression, the immunonutrition may make it easier for the body to adapt to systemic inflammation and oxidative stress induced by RCTs and may improve three-year survival (25,41–43). However, further studies focusing on the timing, dosage and duration of immunonutrition in HNC patients are awaited.In conclusion, HNC patients undergoing cancer treatment are at high risk of malnutrition before, during and after oncological care. The nutritional screening, assessment and support play a crucial role on the maintenance of nutritional status providing specific interventions such as oral nutritional supplements increasing dietary intake and preventing therapy-associated weight loss. It is well-reported in literature that the interruption of CRT may contribute to worse oncological outcomes. In this regard, the present overview highlighted that an adequate nutritional screening, assessment and interventions might increase the adherence of HNC patients to oncological treatments and encourages radiation oncologists to set up multidisciplinary care paths.
No takes yet. Share an insight, caveat, or question.
Santo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: